Andrew N. Gale

464 citations
19 papers · 249 indexed · h-index 12

Andrew N. Gale

19 papers receiving 246 citations

Peers

Andrew N. Gale
Comparison fields: 5 of 65
  • Complementary and Manual Therapy 8
  • Infectious Diseases 46
  • Molecular Biology 105
  • Epidemiology 52
  • Hematology 16
Replace Saule Nurmukhambetova with:
Saule Nurmukhambetova United States
Kevin Pérez Switzerland
Cindy Rechner Germany
Krystal J. Vail United States
Francisco Javier Estrada-Mena Mexico
Mohammad R. Hasan Germany
Jeongmin Yu South Korea
Yumi Tagawa Japan
Erik Ulfhammer Sweden
M. Roberts United Kingdom
Andrew N. Gale relative to Saule Nurmukhambetova United States Saule Nurmukhambetova's profile →
Citations per field
00.5×2.7×
Saule Nurmukhambetova · 1×
Citations per year

Countries citing papers authored by Andrew N. Gale

Since Specialization
Citations

This map shows the geographic impact of Andrew N. Gale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew N. Gale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew N. Gale more than expected).

Fields of papers citing papers by Andrew N. Gale

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew N. Gale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew N. Gale. The network helps show where Andrew N. Gale may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Andrew N. Gale, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andrew N. Gale Line = papers co-authored together Andrew N. Gale links everyone, so they are left out of the graph.

All Works

19 of 19 papers shown
#Work
1 20252
2 20242
3 20246
4 202315
5 20212
6 202027
7 202014
8 201934
9 201917
10 201317
11 200122
12 199917
13 19931
14 19911
15 198217
16 197915
17 197812
18 19783
19 197725

About Andrew N. Gale

Andrew N. Gale is a scholar working on Complementary and Manual Therapy, Orthodontics and Infectious Diseases, having authored 19 papers that have together received 249 indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (4 papers), Muscle Physiology and Disorders (2 papers), Plant-Microbe Interactions and Immunity (2 papers), Genomics and Phylogenetic Studies (2 papers), Nuclear Structure and Function (2 papers), Fungal Infections and Studies (2 papers), Fungal and yeast genetics research (2 papers) and Acute Myeloid Leukemia Research (1 paper). The work is most often cited by research in Complementary and Manual Therapy (8 citations), Infectious Diseases (46 citations) and Molecular Biology (105 citations). Andrew N. Gale has collaborated with scholars based in United States, United Kingdom and Israel. Frequent co-authors include Edmond A. Murphy, Kyle W. Cunningham, Judith Berman, R. A. Weeks, Victor A. McKusick, L. W. Duchen, Grover M. Hutchins, Shawn M. Gomez, Vincent L. Gott and P. K. Thomas. Their work appears in journals such as Brain, CHEST Journal and Journal of Neurology Neurosurgery & Psychiatry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026